Unlike the CRC cells used here, downregulation of PAD4 in breast cancer cells30 resulted in increased EMT markers Smad4 and p-Smad2, while overexpression of PAD4 in lung cancer cells31 inhibited EMT through suppression of Elk1. The gene discussed is SMAD2; the disease is lung carcinoma.